Bruna Velosa Ferreira/LinkedIn
Jun 17, 2026, 14:54
Bruna Velosa Ferreira: PV and ET – Beyond Blood Count Control
Bruna Velosa Ferreira, Hematologist at the Champalimaud Clinical Center, shared a post on LinkedIn:
“PV and ET: Beyond Blood Count Control
Three themes that repeatedly emerged across the MPN sessions at EHA2026:
- Disease modification in PV and ET.
- Markers of biological disease activity beyond conventional risk stratification.
- Emerging therapeutic approaches targeting different aspects of MPN biology, including iron metabolism and mutant CALR.
These are exciting developments for the field, and it will be fascinating to follow how these concepts evolve in the coming years.”
Stay updated with Hemostasis Today.
-
Jun 17, 2026, 11:45Advancing Patient-Centred Innovation in Thalassaemia Care at EHA2026 – TIF
-
Jun 17, 2026, 11:37Alessandro Lucchesi: Mechanistic Biology as the Engine of Next-Generation Therapies
-
Jun 17, 2026, 11:23Gabriela Hobbs: Emerging Myelofibrosis Therapies at EHA 2026
-
Jun 17, 2026, 09:54Shadi Tabibian: Improving Outcomes Through Accurate VWD Subclassification
-
Jun 17, 2026, 09:47Nihal Mesmoudi: Inspired by Scientific Excellence at ICMES 2026
-
Jun 17, 2026, 09:26Nicolas Gendron: Join the Conversation on Antithrombotic Stewardship at ISTH 2026
-
Jun 17, 2026, 09:19Natalia Schütz: Translating Scientific Advances into Better Patient Outcomes
-
Jun 17, 2026, 05:21Finn Guo: Exploring Payment Mechanisms for Innovative Hemophilia Therapies
-
Jun 17, 2026, 04:59Wolfgang Miesbach: One-Time CRISPR Therapy Reduces Hereditary Angioedema Attacks by 87%